Showing results (211-220 of 378) with videos related to
Sort By:
Pageof 38
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2004
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancerMatthew R Sydes, Richard J Stephens, A Rollo Moore, et al.British Journal of Cancer|January 27, 2017
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)Ananya Choudhury, Catharine M West, Nuria Porta, et al.Research Square|September 18, 2023
The canonical HPA axis facilitates and maintains light adaptive behaviorHan Lee, Soaleha Shams, Viet Ha Dang Thi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic reviewZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.Australian Health Review : a Publication of the Australian Hospital Association|January 27, 2025
The impact of COVID-19 on public and private emergency departments in Queensland, AustraliaAmy L Sweeny, Emma Hall, Anthony Padowitz, et al.Emergency Medicine Australasia : EMA|June 4, 2026
Identifying Symptom Clusters Predictive of Acute Myocardial Infarction for Aboriginal and Torres Strait Islander and Non-Indigenous AustraliansJaimi Greenslade, William Parsonage, Laura Stephensen, et al.European Urology Open Science|July 13, 2023
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled TrialGe Yu, Stephen Rice, Rakesh Heer, et al.The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.European Radiology|August 24, 2023
The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastasesRicardo Donners, Nina Tunariu, Holly Tovey, et al.Clinical and Translational Radiation Oncology|June 22, 2018
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancerAnna Wilkins, Christine Stuttle, Shama Hassan, et al.Pageof 38